Streetbeat News

Products Services

TNON

Tenon Medical has priced a public offering of 1.22 million shares and warrants, raising $4.5 million to advance its sacroiliac joint solutions.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:47 am

BABA

Alibaba Group has launched an AI-driven English version of its Taobao app in Singapore, quickly topping the App Store charts. This move is part of Alibaba's strategy to expand globally and leverage AI technology. Despite some feature improvements needed, the app's success highlights Alibaba's commitment to enhancing user experience and operational efficiency.

Portfolio Pulse from Benzinga Neuro

September 13, 2024 | 6:08 am

AAPL

Huawei's Mate XT Ultimate Design is challenging Apple's iPhone in China, but its screen replacement costs are notably high. The Mate XT's price and features are part of Huawei's strategy to compete with Apple's iPhone 16 series, which has faced criticism in China for lacking AI features.

Portfolio Pulse from Ananya Gairola

September 13, 2024 | 5:34 am

WLD

XRP

Worldcoin (WLD) and XRP saw significant gains, with WLD rising over 9% following OpenAI's 'o1' model launch, and XRP increasing by 4.42% after Grayscale launched a new XRP Trust.

Portfolio Pulse from Aniket Verma

September 13, 2024 | 4:24 am

META

Meta Platforms' social media platform, Threads, is reportedly using engagement baiting to boost user interaction. This strategy, which favors posts with high comment counts, has led to increased user engagement. Threads reached 200 million active users in August 2024, showcasing its growth.

Portfolio Pulse from Ananya Gairola

September 13, 2024 | 3:48 am

META

SNAP

Meta, Snap, and TikTok have launched a joint initiative called Thrive to combat suicide and self-harm content online. This program allows the companies to share 'signals' to notify each other about such content. The initiative is in response to growing concerns about the safety of social media platforms for young users.

Portfolio Pulse from Ananya Gairola

September 13, 2024 | 3:44 am

NLCP

The potential rescheduling of cannabis by the DEA is a critical issue for the cannabis industry, with a key hearing scheduled for December 2024. Experts discussed the procedural and political challenges that could delay the process, emphasizing that while rescheduling is a positive step, full descheduling is the ultimate goal for effective regulation.

Portfolio Pulse from Nicolás Jose Rodriguez

September 13, 2024 | 3:06 am

AAVE

Donald Trump announced the launch of his cryptocurrency venture, World Liberty Financial, on X spaces. The project aims to promote U.S. dollar-pegged stablecoins and has partnered with Aave. Trump's pro-crypto stance may influence future regulations.

Portfolio Pulse from Aniket Verma

September 13, 2024 | 1:35 am

AAPL

Huawei's new Mate XT tri-fold smartphone, priced at $2,800, challenges Apple's iPhone 16 series in China. Despite its high cost, the Mate XT has garnered significant pre-orders, indicating strong consumer interest. Apple's market share in China has declined, while Huawei's has increased.

Portfolio Pulse from Ananya Gairola

September 13, 2024 | 12:53 am

ATAI

AWAKNF

CMPS

MBIO

NUMIF

The FDA has delayed the approval of MDMA-assisted psychotherapy for PTSD, requiring an additional phase 3 trial. Lykos Therapeutics is working to address the FDA's concerns. Meanwhile, other companies like Atai Life Sciences, Numinus Wellness, Compass Pathways, MindBio Therapeutics, and Awakn Life Sciences are advancing their psychedelic treatments for various psychiatric conditions.

Portfolio Pulse from Juan Spínelli

September 13, 2024 | 12:28 am